Paloma Cejas

9.2k total citations · 1 hit paper
72 papers, 4.5k citations indexed

About

Paloma Cejas is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Paloma Cejas has authored 72 papers receiving a total of 4.5k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Molecular Biology, 27 papers in Oncology and 22 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Paloma Cejas's work include Colorectal Cancer Treatments and Studies (14 papers), Epigenetics and DNA Methylation (12 papers) and Genetic factors in colorectal cancer (12 papers). Paloma Cejas is often cited by papers focused on Colorectal Cancer Treatments and Studies (14 papers), Epigenetics and DNA Methylation (12 papers) and Genetic factors in colorectal cancer (12 papers). Paloma Cejas collaborates with scholars based in Spain, United States and Canada. Paloma Cejas's co-authors include Cristóbal Belda-Iniesta, Manuel González-Barón, Javier de Castro, Juan Ángel Fresno Vara, E. Casado, Jaime Feliú, Henry W. Long, Enrique Casado, Juan Moreno‐Rubio and Manuel Nistal and has published in prestigious journals such as Cell, Nature Communications and Nature Genetics.

In The Last Decade

Paloma Cejas

71 papers receiving 4.5k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

PI3K/Akt signalling pathway and cancer

2003 1.9k citations E. Casado, Javier de Castro et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Paloma Cejas	2.9k	1.3k	1.3k	832	479	72	4.5k
Sarki A. Abdulkadir	2.6k 0.9×	1.2k 1.0×	881 0.7×	998 1.2×	518 1.1×	93	4.4k
Libero Santarpia	3.3k 1.1×	1.8k 1.4×	2.2k 1.8×	773 0.9×	439 0.9×	89	5.4k
Pixu Liu	3.1k 1.1×	1.2k 0.9×	731 0.6×	563 0.7×	450 0.9×	44	4.4k
Claudio Festuccia	2.8k 1.0×	1.6k 1.3×	1.1k 0.9×	1.1k 1.4×	313 0.7×	164	5.3k
Michael Grusch	2.9k 1.0×	1.1k 0.9×	783 0.6×	646 0.8×	303 0.6×	161	4.7k
Remond J.A. Fijneman	2.0k 0.7×	1.3k 1.0×	1.2k 1.0×	556 0.7×	699 1.5×	130	4.1k
Sankar Addya	2.4k 0.8×	1.1k 0.8×	1.4k 1.1×	361 0.4×	351 0.7×	106	4.2k
Wen‐Chun Hung	3.1k 1.1×	1.5k 1.2×	1.2k 0.9×	367 0.4×	349 0.7×	143	5.3k
Christopher L. Morton	3.2k 1.1×	1.5k 1.2×	663 0.5×	915 1.1×	406 0.8×	128	5.6k
Paweł Surowiak	2.3k 0.8×	1.3k 1.0×	930 0.7×	622 0.7×	283 0.6×	97	3.7k

Countries citing papers authored by Paloma Cejas

Since Specialization

Citations

This map shows the geographic impact of Paloma Cejas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paloma Cejas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paloma Cejas more than expected).

Fields of papers citing papers by Paloma Cejas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paloma Cejas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paloma Cejas. The network helps show where Paloma Cejas may publish in the future.

Co-authorship network of co-authors of Paloma Cejas

This figure shows the co-authorship network connecting the top 25 collaborators of Paloma Cejas. A scholar is included among the top collaborators of Paloma Cejas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paloma Cejas. Paloma Cejas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wadosky, Kristine M., Neha Jaiswal, Xueji Zhang, et al.. (2025). EZH2 Suppression Diversifies Prostate Cancer Lineage Variant Evolution and Lacks Efficacy in Inhibiting Disease Progression. Cancer Research. 86(4). 889–908.

Shirole, Nitin H., Yenarae Lee, Amy Goodale, et al.. (2025). Requirement for Cyclin D1 Underlies Cell-Autonomous HIF2 Dependence in Kidney Cancer. Cancer Discovery. 15(7). 1484–1504. 2 indexed citations

Seehawer, Marco, Zheqi Li, Jun Nishida, et al.. (2024). Loss of Kmt2c or Kmt2d drives brain metastasis via KDM6A-dependent upregulation of MMP3. Nature Cell Biology. 26(7). 1165–1175. 21 indexed citations

Singh, Pratik, Wei Yong Gu, Shariq Madha, et al.. (2024). Transcription factor dynamics, oscillation, and functions in human enteroendocrine cell differentiation. Cell stem cell. 31(7). 1038–1057.e11. 6 indexed citations

Heredia-Soto, Victoria, Ismael Ghanem, Laura Guerra, et al.. (2023). The Relationship between the Expression of GATA4 and GATA6 with the Clinical Characteristics and Prognosis of Resectable Pancreatic Adenocarcinoma. Biomedicines. 11(2). 252–252. 5 indexed citations

Jong, Joep J. de, Begoña P. Valderrama, Júlia Perera‐Bel, et al.. (2022). Non-muscle-invasive micropapillary bladder cancer has a distinct lncRNA profile associated with unfavorable prognosis. British Journal of Cancer. 127(2). 313–320. 13 indexed citations

Shah, Neel, Nikolas Kesten, Alba Font‐Tello, et al.. (2020). ERG-Mediated Coregulator Complex Formation Maintains Androgen Receptor Signaling in Prostate Cancer. Cancer Research. 80(21). 4612–4619. 11 indexed citations

Chin, Hang Gyeong, Zhiyi Sun, Paloma Cejas, et al.. (2020). Universal NicE-seq for high-resolution accessible chromatin profiling for formaldehyde-fixed and FFPE tissues. Clinical Epigenetics. 12(1). 15 indexed citations

Tay, Rong En, Olamide Olawoyin, Paloma Cejas, et al.. (2020). Hdac3 is an epigenetic inhibitor of the cytotoxicity program in CD8 T cells. The Journal of Experimental Medicine. 217(7). 46 indexed citations

10.

Cabal‐Hierro, Lucía, Peter van Galen, Miguel A. Prado, et al.. (2020). Chromatin accessibility promotes hematopoietic and leukemia stem cell activity. Nature Communications. 11(1). 1406–1406. 39 indexed citations

11.

Cejas, Paloma, Alessia Cavazza, Vı́ctor Moreno, et al.. (2016). Transcriptional Regulator CNOT3 Defines an Aggressive Colorectal Cancer Subtype. Cancer Research. 77(3). 766–779. 19 indexed citations

12.

Pomerantz, Mark M., Fugen Li, David Y. Takeda, et al.. (2015). The androgen receptor cistrome is extensively reprogrammed in human prostate tumorigenesis. Nature Genetics. 47(11). 1346–1351. 266 indexed citations

13.

Custodio, Ana, Juan Moreno‐Rubio, Jorge Aparicio, et al.. (2014). Pharmacogenetic Predictors of Outcome in Patients with Stage II and III Colon Cancer Treated with Oxaliplatin and Fluoropyrimidine-Based Adjuvant Chemotherapy. Molecular Cancer Therapeutics. 13(9). 2226–2237. 10 indexed citations

14.

Vargas, Teodoro, Juan Moreno‐Rubio, Jesús Herránz, et al.. (2014). Genes associated with metabolic syndrome predict disease‐free survival in stage II colorectal cancer patients. A novel link between metabolic dysregulation and colorectal cancer. Molecular Oncology. 8(8). 1469–1481. 26 indexed citations

15.

Custodio, Ana, Juan Moreno‐Rubio, Jorge Aparicio, et al.. (2013). Pharmacogenetic predictors of severe peripheral neuropathy in colon cancer patients treated with oxaliplatin-based adjuvant chemotherapy: a GEMCAD group study. Annals of Oncology. 25(2). 398–403. 44 indexed citations

16.

Casado, E., Víctor Moreno, José Javier Sánchez, et al.. (2011). A Combined Strategy of SAGE and Quantitative PCR Provides a 13-Gene Signature that Predicts Preoperative Chemoradiotherapy Response and Outcome in Rectal Cancer. Clinical Cancer Research. 17(12). 4145–4154. 25 indexed citations

17.

Moreno, Víctor, Paloma Cejas, Jaime Feliú Batlle, et al.. (2009). Prognostic value of carcinoembryonic antigen level in rectal cancer treated with neoadjuvant chemoradiotherapy. International Journal of Colorectal Disease. 24(7). 741–748. 47 indexed citations

18.

Sereno, María, Miguel Ángel García‐Cabezas, Javier de Castro, et al.. (2007). Immunohistochemical expression of p53, Bcl-2, COX-2, C-erb-B2, EPO-R, beta-catenin, and E-cadherin in non tumoral gastric mucous membrane.. PubMed. 50(4). 285–92. 5 indexed citations

19.

Casado, Enrique, Javier de Castro, Cristóbal Belda-Iniesta, et al.. (2007). Molecular markers in colorectal cancer: genetic bases for a customised treatment. Clinical & Translational Oncology. 9(9). 549–554. 9 indexed citations

20.

Espina, Carolina, María Virtudes Céspedes, Miguel Ángel García‐Cabezas, et al.. (2007). A Critical Role for Rac1 in Tumor Progression of Human Colorectal Adenocarcinoma Cells. American Journal Of Pathology. 172(1). 156–166. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact